AIM
ENTX icon

ARK Investment Management’s Entera Bio ENTX Stock Holding History

ARK Investment Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,744
Closed -$5K – 353
2022
Q1 		$5K Sell
1,744
-689,178
-100% -$1.65M ﹤0.01% 350
2021
Q4 		$1.95M Buy
690,922
+7,915
+1% +$29.7K 0.01% 242
2021
Q3 		$3.22M Buy
+683,007
New +$3.5M 0.01% 230

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ARK Investment Management's ENTX Position: Q2 2022 in Review

ARK Investment Management sold out of Entera Bio (ENTX) in Q2 2022, closing a stake of 1,744 shares — an estimated $5K sold.

ARK Investment Management first reported a position in ENTX in Q3 2021 and held it in 3 quarters. The position peaked at $3.22M in Q3 2021. 10 funds tracked by Wall St. Rank hold ENTX as of Q2 2022.

  • ARK Investment Management reported no remaining Entera Bio position as of Q2 2022 after selling out during the quarter.
  • ARK Investment Management sold 1,744 Entera Bio shares in Q2 2022, an estimated $5K.
  • ARK Investment Management first reported a position in Entera Bio in Q3 2021 and held it in 3 quarters.
  • ARK Investment Management's Entera Bio position peaked at $3.22M in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Entera Bio as of Q2 2022.

Based on ARK Investment Management's 13F filing for Q2 2022, filed 11 Jul 2022.